Which fruits are safe and which are dangerous?
Posted On July 16, 2021
NONI fruit extracts are commonly used in cosmetic and food-related industries as a natural alternative to the common sweetener saccharin.
While some studies have found that the extracts may help prevent the development of Type 2 diabetes, they also have been linked to liver, kidney, and colon cancers.
In 2013, researchers in Australia found that consumption of NONI fruits could lead to elevated blood pressure, which could be linked to heart disease.
In 2014, a large study in the United Kingdom found that consuming 3 servings per day of NONIs resulted in an increase in blood pressure that was significantly higher than the placebo group.
In 2017, researchers from the University of Alberta found that exposure to 3 servings of NON-GMO fruits in the form of fruit juices resulted in a significant decrease in serum cholesterol levels.
Some studies also suggest that the fruit extracts can trigger a condition known as “nutritional neurotoxicity.”
Researchers at the University.
of Pennsylvania found that eating the fruit extract of a melon could result in higher blood pressure levels in young adults.
In 2018, a study in France found that 3 servings a day of the extract reduced blood pressure by 4 percent, but that the amount of the fruit was still low enough that it wasn’t enough to be considered a health risk.
In 2019, researchers at the Université Paris-Sud found that 1 serving of the melon extract caused a significant increase in serum concentrations of the stress hormone cortisol.
Researchers also found that a 3-ounce serving of melon juice caused an increase of cortisol levels that was similar to the amount found in drinking soda.
In 2020, a German study found that melon extracts were linked to elevated levels of a protein called glutathione peroxidase (GPx).
In 2021, a Spanish study found a significant effect of melons on levels of inflammatory cytokines and TNF-alpha in the blood of patients with rheumatoid arthritis.
In 2021 and 2022, researchers reported that the use of melas could lead people to develop Type 2 Diabetes.
In the US, the Food and Drug Administration (FDA) approved the use in humans of melonic extracts as a treatment for Type 2 Diabetic Crohn’s Disease in 2017.
In 2024, researchers found that 2 ounces of melones contained 25 to 50 percent more fructose than sugar, and that the fructose content of melo-containing drinks increased with the amount that was consumed.
In 2025, the FDA approved the usage of melonyls as a diabetes prevention strategy in patients with Type 2 DM.
In 2022, a small study in China found that chronic exposure to melons caused elevated levels and a significant rise in blood glucose levels, which correlated with a reduction in the body’s ability to break down sugars.
In 2016, researchers showed that melonyl and the flavonoids that are derived from melon have antioxidant and anti-inflammatory properties.
In a study published in the British Medical Journal, researchers analyzed blood samples from 447 healthy men and found that they showed significantly lower levels of both oxidative stress and inflammation than those from nonmelon subjects.
The researchers also found evidence of an increase within the mitochondria of cells exposed to oxidative stress, which is a type of damage to the energy-producing pathways of cells.
Researchers believe that melons have been used as a diet supplement for decades to promote weight loss, and as a replacement for sugar in processed foods, especially those with added sugars and preservatives.
Some reports suggest that melonic extract has been shown to lower LDL cholesterol levels in overweight adults, which has led some people to avoid eating sugar-sweetened foods, as well as the consumption of refined grains and processed foods.
The FDA approved melonyliscent as a dietary supplement in 2006.
In 2008, the NIH released a study of the effects of melosols on lipid metabolism in people with type 2 DM, which found that these extracts reduced the activity of a type 2 diabetes gene.
A large study published last year in the New England Journal of Medicine found that when researchers infused melo, the combination of mela, a flavonoid and vitamin C, into the bloodstream, they were able to decrease blood glucose and insulin levels and increase the activity and number of the gene that regulates the liver’s ability the liver to metabolize sugar.
In 2009, researchers identified a mechanism by which melo can decrease inflammation in the liver.
Melo-derived extracts have also been linked with weight loss and a reduction of blood pressure in patients suffering from Type 2, Type 1, or Type 2DM.
The effects of the fruits and other melons are not limited to food, however.
According to a 2017 study published by the American Journal of Clinical Nutrition, the use for non-alcoholic fatty liver disease and related conditions could lead a person to have an improved risk of developing cancer.
A 2016 study published on the University Health Network found that non-melon extracts and flavonols may reduce the incidence of gast